- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01047826
M.I.P.O. vs Intramedullary Nailing in Tibia Fractures (MINT)
Intramedullary Nailing vs. M.I.P.O. in Fractures of the Tibia a Randomized Controlled Trial
The investigators are comparing two methods of standard treatments in distal tibial fractures. locked plating (M.I.P.O. technique) with intramedullary nailing.
the investigators are hypothesizing that M.I.P.O group is superior to nailing in fractures of the distal third of the tibia.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Central
-
Riyadh, Central, Saudi Arabia, 11426
- Recruiting
- King Abdullah International Medical Research Center
-
Contact:
- Husam A AL-Rumaih, MD
- Phone Number: 14119 +96612520088
- Email: rumaih@me.com
-
Contact:
- Sami I AL-Essia, MD
- Phone Number: 14119 +96612520088
- Email: saleissa@yahoo.com
-
Principal Investigator:
- Wael S Taha, MD
-
Sub-Investigator:
- Abdulaziz AL-Ammari, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Males and Females aged from 18-60 years
- Closed Tibia Fracture
- Tibia Fracture Müller AO Class 43-A
Exclusion Criteria:
- Intra-articular Fractures
- Open fractures
- fracturesSubjects with documented Marfan's syndrome or Ehlers-Danlos syndrome or Hajdu-Cheney syndrome.
- Post organ transplant patients (except Cornea transplant)
- Subjects on immunosuppressive medications
Subjects with diagnosed with
- Osteogenesis imperfecta
- Osteopetrosis
- Paget disease of bone
- Renal osteodystrophy
- Subjects with diagnosed neoplasms or mitotic illnesses
- Subjects receiving growth hormone
- Unable to comply with postoperative rehabilitation e.g. head injury
- Impending compartment syndrome
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: M.I.P.O. Group
subjects who have been randomized to the M.I.P.O. group
|
Fractures well be treated with locked plates using M.I.P.O.
Technique
Other Names:
|
|
Experimental: Intramedullary Nail group
Subjects who have been Randomized to the I.M. group
|
Fractures well be fixed using intramedullary nails
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Rate Of Malunion
Time Frame: 6 months
|
Any healing that occurs with any one of the following: More than 5 degree angulation in the anterior-posterior or lateral view or Rotation of more than 10 degrees or Shorting of more than 1 cm. |
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Short Form (12) Health Score (SF-12v2®)
Time Frame: every 3 months till healing or 24 months
|
every 3 months till healing or 24 months
|
|
|
Blood Loss
Time Frame: during the time of surgery
|
during the time of surgery
|
|
|
Radiation exposure
Time Frame: During the time of Surgery
|
During the time of Surgery
|
|
|
Duration of Surgery
Time Frame: During the time of Surgery
|
During the time of Surgery
|
|
|
Infection Rate
Time Frame: every 3 months till healing or 24 months
|
every 3 months till healing or 24 months
|
|
|
Hospital Stay
Time Frame: After Surgery
|
After Surgery
|
|
|
Time Of Fracture Healing
Time Frame: 6 months
|
Clinical Criteria: No pain or tenderness while wight bearing or palpating the fracture site Radiological Criteria: Bridging of the fracture site in anterior-posterior and lateral views. Using these two criteria we well be able to measure the time of healing in our study subjects. |
6 months
|
Collaborators and Investigators
Investigators
- Principal Investigator: Husam A AL-Rumaih, MD, National Guard Heath Affaires, Saudi Arabia
- Study Director: Wael S Taha, MD, National Guard Health Affairs
- Study Chair: Sami I AL-Essia, MD, National Guard Health Affairs
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- RC09/128
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.